Elanco has begun marketing Surolan (miconazole nitrate and polymyxin B), a leading otic suspension around the world for more than three decades. Surolan has antibacterial, antifungal and anti-inflammatory benefits and is indicated for the treatment of canine otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius). For the past four years, it has been marketed in the U.S. by Vetoquinol. Through Elanco's acquisition of Janssen Animal Health, Elanco has taken over the manufacturing, marketing and selling of the product. 
2500 Innovation Way Greenfield, IN 46140
Tel: 1-888-545-5973